A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy
Condition: Urinary Incontinence · Sponsor: Astellas Pharma Inc
About this study
The purpose of this study is to assess the efficacy and safety of 12 weeks of treatment of solifenacin succinate versus placebo in participants who are incontinent after Robotic Assisted Radical Prostatectomy. This study will also assess the effect of 12 weeks of treatment with solifenacin succinate versus placebo on quality of life (QOL) as measured by questionnaires.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (60)
| Urology Centers of Alabama | Homewood, Alabama, United States | — |
| Alaska Clinical Research Center | Anchorage, Alaska, United States | — |
| Urological Associates of Southern Arizona | Tucson, Arizona, United States | — |
| University of California, San Diego Moores Cancer Center | La Jolla, California, United States | — |
| Tower Urology | Los Angeles, California, United States | — |
| Radiological Associates of Sacramento Medical Group, Inc. | Sacramento, California, United States | — |
| Urology Center of Colorado | Denver, Colorado, United States | — |
| Urology Associates | Englewood, Colorado, United States | — |
| Advanced Urology | Parker, Colorado, United States | — |
| Connecticut Clinical Research Center | Middlebury, Connecticut, United States | — |
| Grove Hill Medical Center | New Britain, Connecticut, United States | — |
| Urologic Surgeons of Washington | Washington D.C., District of Columbia, United States | — |
+ 48 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01371994